Raed Alserihi
-
- Acute Myeloid Leukemia Research 4
-
- Computational Drug Discovery Methods 2
-
- Acute Lymphoblastic Leukemia research 6
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
-
- CAR-T cell therapy research 2
-
- Renal and related cancers 2
-
- Cholinesterase and Neurodegenerative Diseases 2
- Co-authors
- Shams TabrezTorki A. ZughaibiMatthew P. McCormackMohamed F. AlajmiMohd Shahnawaz KhanMd Tabish RehmanNasimudeen R. JabirBadar ul Islam
- Partner nations
- Saudi ArabiaAustraliaIndia
In The Last Decade
Raed Alserihi
18 papers receiving 243 citations
Peers
Comparison fields: 5 of 79
- Hematology 40
- Toxicology 8
- Computational Theory and Mathematics 31
- Biochemistry 11
- Pharmaceutical Science 11
Countries citing papers authored by Raed Alserihi
This map shows the geographic impact of Raed Alserihi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raed Alserihi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raed Alserihi more than expected).
Fields of papers citing papers by Raed Alserihi
This network shows the impact of papers produced by Raed Alserihi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raed Alserihi. The network helps show where Raed Alserihi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raed Alserihi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 19 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 37 | |
| 12 | 2021 | 37 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 1 | |
| 17 | 2021 | 0 | |
| 18 | 2016 | 45 | |
| 19 | 2015 | 7 | |
| 20 | 2014 | 17 |
About Raed Alserihi
Raed Alserihi is a scholar working on Hematology, Management of Technology and Innovation and Cancer Research, having authored 22 papers that have together received 246 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (4 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), CAR-T cell therapy research (2 papers), Computational Drug Discovery Methods (2 papers), Renal and related cancers (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Hematology (40 citations), Toxicology (8 citations) and Computational Theory and Mathematics (31 citations). Raed Alserihi has collaborated with scholars based in Saudi Arabia, Australia and India. Frequent co-authors include Shams Tabrez, Torki A. Zughaibi, Matthew P. McCormack, Mohamed F. Alajmi, Mohd Shahnawaz Khan, Md Tabish Rehman, Nasimudeen R. Jabir, Badar ul Islam, Mohammed Kaleem and Mohd Suhail. Their work appears in journals such as Leukemia, Phytotherapy Research, Nanotechnology Reviews, Journal of Cellular Physiology and Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.